RCM
COCH icon

Rivernorth Capital Management’s Envoy Medical COCH Stock Holding History

Rivernorth Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-52,647
Closed -$297K – 492
2023
Q3 		$297K Hold
52,647
– – 0.02% 258
2023
Q2 		$539K Hold
52,647
– – 0.03% 256
2023
Q1 		$526K Sell
52,647
-208,653
-80% -$2.09M 0.03% 307
2022
Q4 		$2.62M Buy
+261,300
New +$2.6M 0.12% 161

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rivernorth Capital Management's COCH Position: Q4 2023 in Review

Rivernorth Capital Management sold out of Envoy Medical (COCH) in Q4 2023, closing a stake of 52,647 shares — an estimated $297K sold.

Rivernorth Capital Management first reported a position in COCH in Q4 2022 and held it in 4 quarters. The position peaked at $2.62M in Q4 2022. 9 funds tracked by Wall St. Rank hold COCH as of Q4 2023.

  • Rivernorth Capital Management reported no remaining Envoy Medical position as of Q4 2023 after selling out during the quarter.
  • Rivernorth Capital Management sold 52,647 Envoy Medical shares in Q4 2023, an estimated $297K.
  • Rivernorth Capital Management first reported a position in Envoy Medical in Q4 2022 and held it in 4 quarters.
  • Rivernorth Capital Management's Envoy Medical position peaked at $2.62M in Q4 2022.
  • 9 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2023.

Based on Rivernorth Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.